New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: Useful combined test for diagnosis of systemic candidiasis

Journal of Clinical Microbiology

Volumn 37, Issue 5, 1999, Pages 1510-1517

  Sendid, Boualem ^a   Tabouret, Marc ^b   Poirot, Jean Louis ^c   Mathieu, Daniel ^d   Fruit, Jeanine ^a   Poulain, Daniel ^a  

^a INSERM   (France)

^b SANOFI   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; MANNAN;

ADULT; AGED; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FEMALE; FUNGEMIA; FUNGUS IDENTIFICATION; HUMAN; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SERODIAGNOSIS; SERUM; STANDARDIZATION;

CANDIDA ALBICANS; FUNGI;

EID: 0032897577     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.5.1510-1517.1999     Document Type: Article

References (74)

1. Armstrong, D. 1989. Problems in management of opportunistic fungal diseases. Rev. Infect. Dis. 11(Suppl. 7):1591-1599.
2. Ashman, R. B., and J. M. Papadimitriou. 1995. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59:646-672.
3. Bailey, J. W., E. Sada, C. Brass, and J. E. Bennett. 1985. Diagnosis of systemic candidiasis by latex agglutination for serum antigen. J. Clin. Microbiol. 21:749-752.
4. Bodey, G. P. (ed.). 1993. Candidiasis. Pathogenesis, diagnosis and treatment, 2nd ed. Raven Press, New York, N.Y.
5. Burnie, J. P., N. Golbang, and R. C. Matthews. 1997. Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 16:346-350.
6. Calderone, R., E. Enache, T. Eskandari, E. Wadsworth, and J. Sturtevant. 1997. Adherence of Candida albicans to mammalian cells in vitro: nutritional influences, p. 75-83. In S. Suzuki and M. Suzuki (ed.), Fungal cells in biodefense mechanisms. Salken Publishing Co., Tokyo, Japan.
7. Calderone, R. A., and P. C. Braun. 1991. Adherence and receptor relationships of Candida albicans. Microbiol. Rev. 55:1-20.
8. Cassone, A. 1989. Cell wall of Candida albicans: its functions and its impact on the host. Curr. Top. Med. Mycol. 3:248-314.
9. Castro, M., N. V. Ralston, T. I. Morgenthaler, M. S. Rohrbach, and A. H. Limper. 1994. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect. Immun. 62:3138-3145.
10. Daniel, P. F., B. Winchester, and C. D. Warren. 1994. Mammalian alphamannosidases - multiple forms but a common purpose? Glycobiology 4:551-566.
11. De Bernardis, F., C. Girmenia, M. Boccanera, D. Adriani, P. Martino, and A. Cassone. 1993. Use of a monoclonal antibody in a dot immunobinding assay for detection of a circulating mannoprotein of Candida spp. in neutropenic patients with invasive candidiasis. J. Clin. Microbiol. 31:3142-3146.
12. Faille, C., D. W. Mackenzie, J. C. Michalski, and D. Poulain. 1992. Evaluation of an enzyme immunoassay using neoglycolipids constructed from Candida albicans oligomannosides to define the specificity of anti-mannan antibodies. Eur. J. Clin. Microbiol. Infect. Dis. 11:438-446.
13. 1H-NMR spectroscopy of manno-oligosaccharides of the β-1,2-linked series released from the phosphopeptidomannan of Candida albicans VW32 (serotype A). Biochem. Biophys. Res. Commun. 181:1251-1258.
14. Field, B., D. Knipe, and P. Holley. 1996. Diagnostic virology, p. 401-430. In L.-R. Press (ed.), Field virology, 3rd ed. Lippincott-Raven Press, Philadelphia, Pa.
15. Flahaut, M., D. Sanglard, M. Monod, J. Bille, and M. Rossier. 1998. Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J. Clin. Microbiol. 36:395-401.
16. Fradin, C., T. Jouault, A. Mallet, J. M. Mallet, D. Camus, P. Sinay, and D. Poulain. 1996. Beta-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J. Leukoc. Biol. 60:81-87.
17. Fukazawa, Y. 1989. Antigenic structure of Candida albicans. Immunochemical basis of the serologic specificity of the mannans in yeasts. Immunol. Ser. 47:37-62.
18. Gentry, L. O., I. D. Witkinson, A. S. Lea, and M. F. Price. 1983. Latex agglutination test for detection of Candida antigen in patients with disseminated disease. Eur. J. Clin. Microbiol. 2:122-128.
19. Han, Y., T. Kanbe, R. Cherniak, and J. E. Cutler. 1997. Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect. Immun. 65:4100-4107.
20. Heidenreich, F., and M. P. Dierich. 1985. Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b. Infect. Immun. 50:598-600.
21. Herent, P., D. Stynen, F. Hernando, J. Fruit, and D. Poulain. 1992. Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidiasis. J. Clin. Microbiol. 30:2158-2164.
22. Jacquinot, P. M., Y. Plancke, B. Sendid, G. Strecker, and D. Poulain. 1999. Nature of Candida albicans-derived carbohydrate antigen recognized by a monoclonal antibody in patients sera and distribution over Candida species. FEMS Microbiol. Lett. 166:131-138.
23. Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
24. Jones, J. M. 1990. Laboratory diagnosis of invasive candidiasis. Clin. Microbiol. Rev. 3:32-45.
25. Kappe, R., and J. Müller. 1991. Rapid clearance of Candida albicans mannan antigens by liver and spleen in contrast to prolonged circulation of Cryptococcus neoformans antigens. J. Clin. Microbiol. 29:1665-1669.
26. Kitz, D., P. Sthal, and J. Little. 1992. The effect of a mannose binding protein on macrophage interaction with Candida albicans. Cell. Mol. Biol. 38:407-412.
27. Klis, F. 1994. Cell wall assembly in yeast. Yeast 10:851-869.
28. Kobayashi, H., M. Komido, M. Watanabe, K. Matsuda, M. Suzuki, T. Ikeda, H. Oyamada, N. Shibata, and S. Suzuki. 1994. Structure of cell wall mannan of Candida kefyr IFO 0586. Infect. Immun. 62:4425-4431.
29. Kobayashi, H., N. Shibata, and S. Suzuki. 1992. Evidence for oligomannosyl residues containing both β-1,2 and α-1,2 linkage as serotype A-specific epitope(s) in mannans of Candida albicans species. Infect. Immun. 60:2106-2109.
30. Kohno, S., K. Mitsutake, S. Maesaki, A. Yasuoka, T. Miyazaki, M. Kaku, H. Koga, and K. Hara. 1993. An evaluation of serodiagnostic tests in patients with candidemia: beta-glucan, mannan, candida antigen by Cand-Tec and D-arabinitol. Microbiol. Immunol. 37:207-212.
31. Koshi, G., A. Viswanathan, M. Chandy, and P. S. Jairaj. 1987. Development of a coagglutination (COA) technic to detect Candida antigenemia. I. COA versus Candida isolation. Am. J. Clin. Pathol. 88:429-435.
32. Lemieux, C., G. St-Germain, J. Vincelette, L. Kaufman, and L. de Repentigny. 1990. Collaborative evaluation of antigen detection by a commercial latex agglutination test and enzyme immunoassay in the diagnosis of invasive candidiasis. J. Clin. Microbiol. 28:249-253.
33. Li, R. K., and J. E. Cutler. 1993. Chemical definition of an epitope/adhesin molecule on Candida albicans. J. Biol. Chem. 268:18293-18299.
34. Marodi, L., S. Schreiber, D. C. Anderson, R. P. MacDermott, H. M. Korchak, and R. B. Johnston, Jr. 1993. Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Investig. 91:2596-2601.
35. Martinez, J. P., M. L. Gil, J. L. Lopez-Ribot, and W. L. Chaffin. 1998. Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 11:121-141.
36. Matthews, R., J. P. Burnie, and W. Lee. 1991. The application of epitope mapping in the development of a new serological test for systemic candidiasis. J. Immunol. Methods 143:73-79.
37. Matthews, R., S. Hodgetts, and J. Burnie. 1995. Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis. J. Infect. Dis. 171:1668-1671.
38. Meulemans, L., A. Andremont, F. Meunier, A. M. Ceuppens, M. L. Garrigues, and D. Stynen. 1991. Pastorex Candida, a new latex agglutination test for mannan detection in serum of patients with invasive candidiasis, p. 233-236. In E. Tümbay, H. P. R. Seeliger, and Ö. Ang (ed)., Candida and candidamycosis. Plenum Press, New York, N.Y.
39. Mitsutake, K., S. Kohno, T. Miyazaki, H. Miyazaki, S. Maesaki, and H. Koga. 1994. Detection of Candida enolase antibody in patients with candidiasis. J. Clin. Lab. Anal. 8:207-210.
40. Mitsutake, K., T. Miyazaki, T. Tashiro, Y. Yamamoto, H. Kakeya, T. Otsubo, S. Kawamura, M. A. Hossain. T. Noda, Y. Hirakata, and S. Kohno. 1996. Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia. J. Clin. Microbiol. 34:1918-1921.
41. Miyazaki, T., S. Kohno, K. Mitsutake, S. Maesaki, K. Tanaka, N. Ishikawa, and K. Hara. 1995. Plasma (1→3)-beta-D-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J. Clin. Microbiol. 33:3115-3118.
42. Nelson, R. D., N. Shibata, R. P. Podzorski, and M. J. Herron. 1991. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action. Clin. Microbiol. Rev. 4:1-19.
43. Obayashi, T., M. Yoshida, T. Mori, H. Goto, A. Yasuoka, H. Iwasaki, H. Teshima, S. Kohno, A. Horiuchi, A. Ito, et al. 1995. Plasma (1→3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 345:17-20.
44. Odds, F. C. (ed.). 1988. Candida and candidiasis. A review and bibliography. Baillière Tindall, London, United Kingdom.
45. Odds, F. C., and G. Evans. 1980. Distribution of pathogenic yeasts and humoral antibodies to Candida among hospital inpatients. J. Clin. Pathol. 33:750-756.
46. Osumi, M. 1998. The ultrastructure of yeast: cell wall structure and formation. Micron 29:207-233.
47. Pittel, D. 1993. Nosocomial bloodstream infections, p. 512-555. In R. P. Wenzel (ed.), Prevention and control of nosocomial infections, 2nd ed. The Williams & Wilkins Co., Baltimore, Md.
48. Poulain, D., C. Faille, C. Delaunoy, P. Jacquinot, P. Trinel, and D. Camus. 1993. Probable presence of β(1-2)-linked oligomannosides that act as human immunoglobulin G3 epitopes and are distributed over a Candida albicans 14-to 18-kilodalton antigen. Infect. Immun. 61:1164-1166.
49. Poulain, D., T. Jouault, and P. Trinel. 1997. Immunoreactivity of Candida albicans β-1,2-linked oligomannosides and phospholipomannan, p. 175-181. In S. Suzuki and M. Suzuki (ed.), Fungal cells in biodefense mechanisms. Salken Publishing Co., Tokyo, Japan.
50. Poulain, D., and J. M. Pinon. 1986. Diagnosis of systemic candidiasis: development of co-counterimmunoelectrophoresis. Eur. J. Clin. Microbiol. 5:420-426.
51. Poulain, D., R. Robert, F. Mesnard, B. Sendid, G. Lepage, and D. Camus. 1997. Clearances of Candida albicans-derived alpha- and beta-linked mannose residues in sera from patients with candidiasis. Eur. J. Clin. Microbiol. Infect. Dis. 16:16-20.
52. Quinton, J. F., B. Sendid, D. Reumaux, P. Duthilleul, A. Cortot, B. Grandbastien, G. Charrier, S. Targan, J. F. Colombel, and D. Poulain. 1998. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788-791.
53. Reiss, E., and C. J. Morrison. 1993. Nonculture methods for diagnosis of disseminated candidiasis. Clin. Microbiol. Rev. 6:311-323.
54. Reiss, E., L. Stockman, R. J. Kuykendall, and S. J. Smith. 1982. Dissociation of mannan-serum complexes and detection of Candida albicans mannan by enzyme immunoassay variations. Clin. Chem. 28:306-310.
55. Sackett, D. L., R. B. Haynes, and P. Tugwell. 1985. Clinical epidemiology. The interpretation of diagnostic data, p. 59-138. Little, Brown & Co., Boston, Mass.
56. Saral, R. 1991. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis. 13:487-492.
57. Shepherd, M. G. 1987. Cell envelope of Candida albicans. Crit. Rev. Microbiol. 15:7-25.
58. Shibata, N., M. Arai, E. Haga, T. Kikuchi, M. Najima, T. Satoh, H. Kobayashi, and S. Suzuki. 1992. Structural identification of an epitope of anti-genie factor 5 in mannans of Candida albicans NIH B-792 (serotype B) and J-1012 (serotype A) as β-1,2-linked oligomannosyl residues. Infect. Immun. 50:4100-4110.
59. Shibata, N., K. Hisamichi, H. Kobayashi, and S. Suzuki. 1993. Complete assignment of 1H and 13C nuclear magnetic resonance chemical shifts of beta-1,2-linked mannooligosaccharides isolated from the phosphomannan of the pathogenic yeast Candida albicans NIH B-792 strain. Arch. Biochem. Biophys. 302:113-117.
60. Stahl, P. D. 1990. The macrophage mannose receptor: current status. Am. J. Respir. Cell. Mol. Biol. 2:317-318.
61. Summerfield, J. A., and M. E. Taylor. 1986. Mannose-binding proteins in human serum: identification of mannose-specific immunoglobulins and a calcium-dependent lectin, of broader carbohydrate specificity, secreted by hepatocytes. Biochim. Biophys. Acta 883:197-206.
62. Suzuki, S. 1997. Immunochemical study on mannans of genus Candida. I. Structural investigation of antigenic factors 1, 4, 5, 6, 8, 9, 11, 13, 13b and 34. Curr. Top. Med. Mycol. 8:57-70.
63. Switchenko, A. C., C. G. Miyada, T. C. Goodman, T. J. Walsh, B. Wong, M. J. Becker, and E. F. Ullman. 1994. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J. Clin. Microbiol. 32:92-97.
64. Talluri, G., C. Mangone, J. Freyle, D. Shirazian, H. Lehman, and G. J. Wise. 1998. Polymerase chain reaction used to detect candidemia in patients with candiduria. Urology 51:501-505.
65. Trinel, P. A., M. Borg-von-Zepelin, G. Lepage, T. Jouault, D. Mackenzie, and D. Poulain. 1993. Isolation and preliminary characterization of the 14-to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta-1,2-linked oligomannosides. Infect. Immun. 61:4398-4405.
66. Trinel, P. A., C. Faille, P. M. Jacquinot, J. C. Cailliez, and D. Poulain. 1992. Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies. Infect. Immun. 60:3845-3851.
67. Tsuchiya, T., Y. Fukazawa, M. Taguchi, T. Kase, and T. Shinoda. 1974. Serologic aspects on yeast classification. Mycopathol. Mycol. Appl. 53:77-91.
68. Van Deventer, A. J., H. Van Vliet, W. Hop, and W. Goessens. 1994. Diagnostic value of anti-Candida enolase antibodies. J. Clin. Microbiol. 32:17-23.
69. Van Deventer, A. J., W. H. Goessens, J. H. van Zeijl, J. W. Mouton, M. F. Michel, and H. A. Verbrugh. 1996. Kinetics of anti-mannan antibodies useful in confirming invasive candidiasis in immunocompromised patients. Microbiol. Immunol. 40:125-131.
70. Vincent, J. L., D. J. Bihari, P. M. Suter, H. A. Bruining, J. White, M. H. Nicolas-Chanoin, M. Wolf. R. C. Spencer, and M. Hemmer. 1995. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639-644.
71. Voss, A., J. A. Kluytmans, J. G. Koeleman, L. Spanjaard, C. M. Vanden-broucke-Grauls, H. A. Verbrugh, M. C. Vos, A. Y. Weersink, J. A. Hoogkamp-Korstanje, and J. F. Meis. 1996. Occurrence of yeast blood-stream infections between 1987 and 1995 in five Dutch university hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 15:909-912.
72. Walsh, T. J., J. W. Hathorn, J. D. Sobel, W. G. Merz, V. Sanchez, S. M. Maret, H. R. Buckley, M. A. Pfaller, R. Schaufele, C. Sliva, et al. 1991. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N. Engl. J. Med. 324:1026-1031.
73. Weiner, M. H., and M. Coats-Stephen. 1979. Immunodiagnosis of systemic candidiasis: mannan antigenemia detected by radioimmunoassay in experimental and human infections. J. Infect. Dis. 140:989-993.
74. Wenzel, R. P. 1995. Nosocomial candidemia: risk factors and attributable mortality. Clin. Infect. Dis. 20:1531-1534.